A team of Brigham and Women’s Hospital researchers have developed a way to bioprint tubular structures that better mimic native vessels and ducts in the body.
The 3-D bioprinting technique allows fine-tuning of the printed tissues’ properties, such as number of layers and ability to transport nutrients. These more complex tissues offer potentially viable replacements for damaged tissue. The team describes its new approach and results in a paper published on Aug. 23 in Advanced Materials.
“The vessels in the body are not uniform,” said Yu Shrike Zhang, PhD, senior author on the study and an associate bioengineer in BWH’s Department of Medicine. “This bioprinting method generates complex tubular structures that mimic those in the human system with higher fidelity than previous techniques.”
Many disorders damage tubular tissues: arteritis, atherosclerosis and thrombosis damage blood vessels, while urothelial tissue can suffer inflammatory lesions and deleterious congenital anomalies.
To make the 3D bioprinter’s “ink,” the researchers mixed the human cells with a hydrogel, a flexible structure composed of hydrophilic polymers. They optimized the chemistry of the hydrogel to allow the human cells to proliferate, or “seed,” throughout the mixture.
Next, they filled the cartridge of a 3D bioprinter with this bio-ink. They fitted the bioprinter with a custom nozzle that would allow them to continuously print tubular structures with up to three layers. Once the tubes were printed, the researchers demonstrated their ability to transport nutrients by perfusing fluids.
The researchers found that they could print tissues mimicking both vascular tissue and urothelial tissue. They mixed human urothelial and bladder smooth muscle cells with the hydrogel to form the urothelial tissue. To print the vascular tissue, they used a mixture of human endothelial cells, smooth muscle cells and the hydrogel.
The printed tubes had varying sizes, thicknesses and properties. According to Zhang, structural complexity of bioprinted tissue is critical to its viability as a replacement for native tissue. That’s because natural tissues are complex. For instance, blood vessels are comprised of multiple layers, which in turn are made up of various cell types.
The team plans to continue preclinical studies to optimize the bio-ink composition and 3D-printing parameters before testing for safety and effectiveness.
“We’re currently optimizing the parameters and biomaterial even further,” said Zhang. “Our goal is to create tubular structures with enough mechanical stability to sustain themselves in the body.”
The Latest on: 3-D bioprinting
via Google News
The Latest on: 3-D bioprinting
- 3D Bioprinting Market Regional Opportunities, Key Country Outlook Growth Insight and Leading Players Forecast Toon January 12, 2021 at 5:31 pm
Market Research Future Introduces the "Global 3D Bioprinting Market" Research Report. Reports Provides the classifications and industry Structure with Top Industry Players, Recent Trends and Industry ...
- The Next Wave of Manufacturing: Human Organson January 10, 2021 at 4:00 pm
Organovo discovered that technology. The company was able to manufacture functional human tissues using 3-D bioprinting technology. Here's how it works: Once a target tissue has been identified, the ...
- We are one step closer to 3D printing human organs in outer spaceon January 5, 2021 at 4:00 pm
You might call it a giant leap for 3D bioprinting: Human heart cells have been 3D printed on the International Space Station (ISS) and are making their way back to Earth this week inside a SpaceX ...
- 3D Bioprinting Market Size USD 9956.9 Million by 2026 at CAGR 18.8% | Valuates Reportson January 4, 2021 at 7:04 am
The global 3D Bioprinting market size is projected to reach USD 9956.9 Million by 2026, from USD 8316 Million in 2020, at a CAGR of 18.8% during 2021-2026. Major factors driving the growth of the ...
- 3D Bioprinting Market Size USD 9956.9 Million by 2026 at CAGR 18.8% | Valuates Reportson January 4, 2021 at 6:35 am
BANGALORE, India, Jan. 4, 2021 /PRNewswire/ -- The 3D Bioprinting Market is Segmented by Type (Magnetic 3D Bioprinting, Laser-assisted Bioprinting, Inkjet 3D Bioprinting, Microextrusion 3D ...
- 3D Bioprinting Market Size USD 9956.9 Million by 2026 at CAGR 18.8% | Valuates Reportson January 4, 2021 at 6:17 am
Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net BANGALORE, India, Jan. 4, 2021 /PRNewswire/ -- The 3D Bioprinting Market is Segmented by Type (Magnetic 3D Bioprinting ...
- 3D Bioprinting Market : insight, Future estimation and Complete Strategic Analysison December 28, 2020 at 11:30 pm
Pune, Maharashtra, India, December 29 2020 (Wiredrelease) MarketResearch.Biz –:“Marketresearch.biz added a new report “Global 3D Bioprinting Market along with its Industry Analysis, Size, Share, ...
- 3D Bioprinting Equipment Market to Watch: Spotlight on OrgaDeco, 3D Biotek, Digilabon December 21, 2020 at 4:00 pm
Dec 22, 2020 (Heraldkeepers) -- An extensive elaboration of the Global 3D Bioprinting Equipment market strategy of the industry players in the precision of import/export consumption, supply and ...
via Bing News